RE:RE:The Big IF Either you must be new here or you don't know this company very well. They have been supposedly trying to partner one or more of their programs for over a decade. They had a (poor) deal at one point for ALS with Biogen that fizzled out when. This was under the previous CEO.
Going back to at least 2018, the company repeatedly noted potential deals with multiple possible companies, which all went nowhere. You might want to review corporate presentations from that time where they threw around numbers such as $50 million upfront and $600 million in milestone payments.
Your idea is good (and rather obvious to everyone); the problem is that current management can't get it done.